Donor Login
Contact Us
JDRF
About
Investment Strategy
Portfolio
Our People
Venture Philanthropy
News
Donor Login
Get in touch
News and Press
Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skin
November 02, 2021
i2O Therapeutics Announces the Appointment of Kurt C. Graves as Executive Chairman
October 12, 2021
SQZ Biotechnologies Announces First Autoimmune Disease Indication for Tolerizing Antigen Carrier (TAC) Platform
September 13, 2021 |
WATERTOWN, MA
Inversago Pharma Initiates a Phase 1 Clinical Trial on INV-202, a Next Generation Peripherally-acting CB1 Blocker
September 07, 2021 |
MONTREAL
GentiBio Announces $157M Series A Financing to Advance Engineered Regulatory T cells as Transformative Therapeutics with Potential to Restore Immune Tolerance and Durably Treat Autoinflammation
August 11, 2021 |
BOSTON, MA
